Figure 5.

A timeline showing the development of tumor organoids. The intestinal stem cells,^{[ 1b ]} OVCAR‐5 ovarian cancer cells,^{[ 200 ]} breast cancer progenitor cells,^{[ 219 ]} colorectal cancer cells,^{[ 1a ]} primary intestinal cancer cells,^{[ 220 ]} EOC cell lines,^{[ 188b ]} advanced prostate cancer cells,^{[ 221 ]} ductal pancreatic cancer cells,^{[ 161 ]} high‐grade serious ovarian cancer cells,^{[ 222 ]} oral cancer stem cells,^{[ 157a ]} rare prostate cancer cells,^{[ 160 ]} and primary EOC cells^{[ 162 ]} represent the prominent cancer types enclosed in this review. The main experimental landmarks involved in ovarian cancer remodeling are denoted by star marks (^*).